Noema Pharma plc (NASDAQ:NOEMW) Shares Shorted: Short Interest Down 65.1% in September

Noema Pharma plc (NASDAQ:NOEMW) was the recipient of a large decline in short interest in the month of September. As of September 30th, there was short interest totaling 883 shares, a decline of 65.1% from the September 15th total of 2,531 shares. Based on an average daily volume of 9,040 shares, the short-interest ratio is presently 0.1 days.

Noema Pharma Stock Performance

NASDAQ NOEMW traded up $0.00 during mid-day trading on Wednesday, reaching $0.10. 425 shares of the stock were exchanged, compared to its average volume of 19,861. The business’s 50 day moving average is $0.14 and its 200-day moving average is $0.12. Noema Pharma has a 1 year low of $0.07 and a 1 year high of $0.24.

Noema Pharma is a clinical-stage biopharmaceutical company focused on developing treatments for rare neurological and neurodevelopmental disorders. The company’s research and development activities center on medicines intended to address conditions with significant unmet medical needs in the central nervous system.

Noema Pharma’s pipeline has included investigational compounds targeting neurological conditions such as fragile X syndrome and tuberous sclerosis complex. Its programs are designed to modulate biological pathways associated with abnormal brain signaling, with development stages and indications subject to change as clinical studies progress.

The company is headquartered in Switzerland and operates internationally through research, clinical development and collaborations with healthcare and biotechnology organizations.